1 / 3

Low risk n =91 Median survival 17.5 years

Supplemental figure 1. Survival data among 614 Mayo Clinic patients with primary myelofibrosis risk-stratified by the International Prognostic Scoring System (IPSS) (from time of within one year of diagnosis). Survival. Low risk n =91 Median survival 17.5 years. P<0.001.

rue
Télécharger la présentation

Low risk n =91 Median survival 17.5 years

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Supplemental figure 1. Survival data among 614 Mayo Clinic patients with primary myelofibrosis risk-stratified by the International Prognostic Scoring System (IPSS) (from time of within one year of diagnosis) Survival Low risk n=91 Median survival 17.5 years P<0.001 Intermediate-1 risk n=161 Median survival 6.8 years High risk n=212 Median survival 2 years Intermediate-2 risk n=150 Median survival 4.6 years Years

  2. Supplemental figure 2. Survival data among 614 Mayo Clinic patients with primary myelofibrosis risk-stratified by the Dynamic International Prognostic Scoring System (DIPSS) (from time of within one year of diagnosis) Survival Low risk n=91 Median survival 17.5 years Intermediate-1 risk n=225 Median survival 6.3 years High risk n=69 Median survival 1.5 years Intermediate-2 risk n=229 Median survival 2.7 years P<0.001 Years

  3. Supplemental figure 3. Survival data among 584 Mayo Clinic patients with primary myelofibrosis risk-stratified by the Dynamic International Prognostic Scoring System (DIPSS)-plus (from time of within one year of diagnosis) Survival Low risk n=76 Median survival 19.2 years Intermediate-1 risk n=116 Median survival 8.1 years High risk n=195 Median survival 1.7 years Intermediate-2 risk n=197 Median survival 4.7 years P<0.001 Years

More Related